MAMegan F. Allen

Megan F. Allen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Megan F. Allen has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors

    by Megan F. Allen, James L. Hutchinson, Michael Keith, Shahida Mallah, Robin A. Corey, Justin S. Trory, Changcheng Jing, Huaquan Fang, Liang Wei, Steven H. Bennett, et al.

    Background and Purpose: Thromboxane A2 (TXA2) is a prostanoid produced during platelet activaton, important in enhancing platelet reactivity by activation of TP receptors. However, due to the short half‐life, studying TXA2 signalling is challenging. To enhance our understanding of TP receptor‐mediated platelet biology, we therefore synthesised mono and difluorinated TXA2 analogues and explored their pharmacology on heterologous and endogenously expressed TP receptor function.Experimental Approach: Platelet functional and signalling responses were studied using aggregometry, Ca2+ mobilisation experiments and immunoblotting and compared with an analogue of the TXA2 precursor prostaglandin H2, U46619. Gαq/Gαs receptor signalling was determined using a bioluminescence resonance energy transfer (BRET) assay in a cell line overexpression system.Key Results: BRET studies revealed that F‐TXA2 and F2‐TXA2 promoted receptor‐stimulated TP receptor G‐protein activation similarly to U46619. Unexpectedly, F2‐TXA2 caused reversible aggregation in platelets, whereas F‐TXA2 and U46619 induced sustained aggregation. Blocking the IP receptor switched F2‐TXA2‐mediated reversible aggregation into sustained aggregation. Further BRET studies confirmed F2‐TXA2‐mediated IP receptor activation. F2‐TXA2 rapidly and potently stimulated platelet TP receptor‐mediated protein kinase C/P‐pleckstrin, whereas IP‐mediated protein kinase A/P‐vasodilator‐stimulated phosphoprotein was more delayed.Conclusion and Implications: F‐TXA2 is a close analogue to TXA2 used as a selective tool for TP receptor platelet activation. In contrast, F2‐TXA2 acts on both TP and IP receptors differently over time, resulting in an initial wave of TP receptor‐mediated platelet aggregation followed by IP receptor‐induced reversibility of aggregation. This study reveals the potential difference in the temporal aspects of stimulatory and inhibitory pathways involved in platelet activation.


  • Open Access

    CryoET reveals actin filaments within platelet microtubules

    by Chisato Tsuji, Marston Bradshaw, Megan Allen, Molly L. Jackson, Judith Mantell, Ufuk Borucu, Alastair W. Poole, Paul Verkade, Ingeborg Hers, Danielle M. Paul, et al.

    Crosstalk between the actin and microtubule cytoskeletons is essential for many cellular processes. Recent studies have shown that microtubules and F-actin can assemble to form a composite structure where F-actin occupies the microtubule lumen. Whether these cytoskeletal hybrids exist in physiological settings and how they are formed is unclear. Here, we show that the short-crossover Class I actin filament previously identified inside microtubules in human HAP1 cells is cofilin-bound F-actin. Lumenal F-actin can be reconstituted in vitro , but cofilin is not essential. Moreover, actin filaments with both cofilin-bound and canonical morphologies reside within human platelet microtubules under physiological conditions. We propose that stress placed upon the microtubule network during motor-driven microtubule looping and sliding may facilitate the incorporation of actin into microtubules.